Rockville, Maryland – October 15, 2026 — The global biosurgery market is projected to grow from USD 29.7 billion in 2026 to USD 47.9 billion by 2036, according to the latest market report published by Fact.MR. The industry is anticipated to expand at a compound annual growth rate (CAGR) of 4.9% over the forecast period, supported by increasing surgical activity and demand for products that control bleeding, seal tissues, and prevent postoperative adhesions.

Get detailed market forecasts, competitive benchmarking, and pricing trends: 

KEY MARKET TAKEAWAYS

• Market Valuation: USD 29.7 billion in 2026, rising to USD 47.9 billion by 2036.
• Growth Rate: Expanding at a CAGR of 4.9% from 2026 to 2036.
• Leading Product Segment: Hemostatic agents account for 46% of the product type segment in 2026.
• Fastest-Growing Country: India leads the covered country markets with a projected CAGR of 5.9%.
• Core Growth Driver: Rising surgical volumes and growing use of biological products for intraoperative bleeding control and tissue sealing.

INDUSTRY SHIFTS & MARKET DYNAMICS

Demand for biosurgery products is increasing as hospitals and surgical teams manage a broad range of cardiovascular, orthopedic, neurological, and general surgical procedures. Hemostatic agents, surgical sealants, tissue adhesives, and adhesion prevention products support bleeding control and tissue management during and after operations. Their use is particularly relevant in complex procedures where conventional suturing, packing, or cauterization may not fully address surgical requirements. The expansion of minimally invasive surgery is also creating demand for products that can be delivered effectively through restricted surgical access points.

Product development is increasingly focused on multifunctional solutions that combine hemostatic performance with tissue repair, antimicrobial protection, or drug delivery capabilities. These innovations may help healthcare providers address multiple surgical needs with fewer separate products. However, higher costs compared with conventional techniques can limit adoption in budget-constrained healthcare systems. Shelf-life requirements, storage conditions for biological formulations, and training needs for newer products also influence procurement decisions. Manufacturers must therefore balance product performance and innovation with affordability, clinical evidence, and reliable distribution.

REGIONAL MARKET SUMMARY

Source: Fact.MR, Biosurgery Market Analysis and Forecast. Country-level growth rates represent projections for 2026–2036.

ANALYST INSIGHTS

“The biosurgery market is a mature but structurally supported category where growth is driven by surgical volume expansion, product innovation, and gradual substitution of conventional hemostasis techniques,” stated Shambhu Nath Jha, Principal Consultant at Fact.MR. “Growth opportunities lie in emerging-market surgical infrastructure expansion, compatibility with minimally invasive procedures, and combination product development that adds functional value beyond basic hemostasis.”

Unlock 360° insights for strategic decision making and investment planning: 

FREQUENTLY ASKED QUESTIONS

Q: What is the projected size of the biosurgery market by 2036?

A: The global biosurgery market is estimated at USD 29.7 billion in 2026 and is projected to reach USD 47.9 billion by 2036, growing at a CAGR of 4.9%.

Q: Which segment holds the leading market share?

A: Hemostatic agents lead the product type segment, accounting for 46% of the market in 2026.

Q: Which country exhibits the highest growth rate?

A: India is projected to lead the covered country markets with a CAGR of 5.9% through 2036, followed by China at 5.6%.

Explore More Related Studies Published by Fact.MR Research

Familial Hypercholesterolemia Treatment Market

Smart Implants Market

About Fact.MR

Fact.MR is a market research and consulting firm providing syndicated research, customized research, investment research, and market intelligence across a broad range of industries. Its research coverage includes food and beverage, healthcare, pharmaceuticals, biotechnology, consumer products, chemicals and materials, technology, industrial goods, and packaging.

Fact.MR provides market intelligence designed to help organizations understand market dynamics, emerging opportunities, competitive developments, and changing industry requirements.

Media Contact

Fact.MR
Email: sales@factmr.com
Phone: +1 (628) 251-1583
Website: www.factmr.com